CAS RN 1373422-53-7

IUPAC Navn: 3-{[2-(pyridin-2-yl)-6-(2,3,4,5-tetrahydro-1H-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoic acid

Synonymer: 3-{[2-(pyridin-2-yl)-6-(1,2,4,5-tetrahydro-3-benzazepin-3-yl)pyrimidin-4-yl]amino}propanoic acid

Molekylvægt (g/mol): 389.46

Molekylformel: C22H23N5O2

InChi Key: AVZCPICCWKMZDT-UHFFFAOYSA-N

SMILES: OC(=O)CCNC1=NC(=NC(=C1)N1CCC2=CC=CC=C2CC1)C1=CC=CC=N1

1 – 2 af 2 Resultater

CAS: 1373422-53-7 Molekylær formel: C22H23N5O2

CAS	1373422-53-7
Molekylær formel	C22H23N5O2

MedChemExpress GSK-J1 is a potent inhibitor of H3K27me3/me2-demethylases JMJD3/KDM6B and UTX/KDM6A, with IC50 of 60 nM towards KDM6B.

Kemisk navn eller materiale	GSK-J1
Sundhedsfare 1	H315∣H319∣H335
Formel vægt	389.45
Opløselighedsinformation	DMSO : 50 mg/mL (128.39 mM; Need ultrasonic)
Procent renhed	99.59%
Fysisk form	Powder
Farve	Brownish Yellow
Grad	Research
Anbefalet opbevaring	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
Molekylvægt (g/mol)	389.45
CAS	1373422-53-7
Holdbarhed	Powder -20°C 3 years, 4°C 2 years∣In solvent -80°C 6 months, -20°C 1 month
SMIL	OC(CCNC1=NC(C2=NC=CC=C2)=NC(N(CC3)CCC4=C3C=CC=C4)=C1)=O
Renhedsgrad noter	Research
Molekylær formel	C₂₂H₂₃N₅O₂
Til brug med (applikation)	Cancer-programmed cell death